SYSTEM AND METHOD FOR DELIVERING THERAPEUTIC AGENT

PROBLEM TO BE SOLVED: To provide a system and a method for delivering a therapeutic agent.SOLUTION: A fragment of a neurotoxin such as an active light chain (LC) of a botulinum toxin (BoNT) such as one of serotype A, B, C, D, E, F, or G botulinum toxin, is applied by transparency of a target cell fi...

Full description

Saved in:
Bibliographic Details
Main Authors HANSON S GIFFORD, DEEM MARK E
Format Patent
LanguageEnglish
Japanese
Published 23.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide a system and a method for delivering a therapeutic agent.SOLUTION: A fragment of a neurotoxin such as an active light chain (LC) of a botulinum toxin (BoNT) such as one of serotype A, B, C, D, E, F, or G botulinum toxin, is applied by transparency of a target cell film, in which the fragment of the neurotoxin is caused to traverse the target cell film and reaches cytoplasm sols of cells in which therapeutic response is generated in a mammal, translocation of a molecule of the botulinum toxin light chain (BoNT-LC) is achieved. The method and device comprise use of a delivery system based on a catheter, a non-invasive delivery system, and a percutaneous delivery system.SELECTED DRAWING: None 【課題】治療薬の送達のためのシステムおよび方法を提供すること【解決手段】血清型A、B、C、D、E、F、またはGボツリヌス毒素の1つなどのボツリヌス毒素(BoNT)の活性軽鎖(LC)などの神経毒のフラグメントを、標的細胞膜の透過化により適用し、標的細胞膜を横断して哺乳類系において治療応答が作り出される細胞の細胞質ゾルに至る、ボツリヌス毒素軽鎖(BoNT−LC)分子のトランスロケーションを可能にする、方法および装置を提供する。この方法および装置は、カテーテルに基づく送達システム、非侵襲性送達システム、および経皮的送達システムの使用を含む。【選択図】なし
Bibliography:Application Number: JP20160227703